Rocket Pharmaceuticals Inc (NASDAQ: RCKT) kicked off on Friday, down -4.42% from the previous trading day, before settling in for the closing price of $6.56. Over the past 52 weeks, RCKT has traded in a range of $4.55-$26.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 16.18%. With a float of $99.77 million, this company’s outstanding shares have now reached $106.75 million.
The firm has a total of 299 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Rocket Pharmaceuticals Inc (RCKT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Rocket Pharmaceuticals Inc is 7.40%, while institutional ownership is 93.41%. The most recent insider transaction that took place on May 20 ’25, was worth 2,301. In this transaction an insider of this company sold 357 shares at a rate of $6.45, taking the stock ownership to the 64,027 shares. Before that another transaction happened on May 20 ’25, when Company’s insider sold 801 for $6.45, making the entire transaction worth $5,163. This insider now owns 235,255 shares in total.
Rocket Pharmaceuticals Inc (RCKT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.67% during the next five years compared to -11.60% drop over the previous five years of trading.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Take a look at Rocket Pharmaceuticals Inc’s (RCKT) current performance indicators. Last quarter, stock had a quick ratio of 9.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.63, a number that is poised to hit -0.57 in the next quarter and is forecasted to reach -1.56 in one year’s time.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
Analysing the last 5-days average volume posted by the [Rocket Pharmaceuticals Inc, RCKT], we can find that recorded value of 2.16 million was lower than the volume posted last year of 2.35 million. As of the previous 9 days, the stock’s Stochastic %D was 47.04%. Additionally, its Average True Range was 0.61.
During the past 100 days, Rocket Pharmaceuticals Inc’s (RCKT) raw stochastic average was set at 19.55%, which indicates a significant decrease from 26.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 120.03% in the past 14 days, which was higher than the 88.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.91, while its 200-day Moving Average is $12.65. Now, the first resistance to watch is $6.43. This is followed by the second major resistance level at $6.59. The third major resistance level sits at $6.76. If the price goes on to break the first support level at $6.11, it is likely to go to the next support level at $5.94. Now, if the price goes above the second support level, the third support stands at $5.78.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Key Stats
The company with the Market Capitalisation of 675.52 million has total of 106,786K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -258,750 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -61,330 K.
